Search
Biochemist Benjamin Tu honored with O’Donnell Award from TAMEST : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/tu-tamest.html
Benjamin Tu, Ph.D., a professor of biochemistry at UT Southwestern whose basic science research into cellular function could lead to greater understanding of diseases including cancer, has been named a recipient of the 2021 Edith and Peter O’Donnell Award in Science, presented by The Academy of Medicine, Engineering and Science of Texas (TAMEST).
Get Our News: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/get-our-news/form-news.html
Get Our News Need help? If you need assistance, please contact the Communications staff at 214-648-3404 . Receive our UT Southwestern News Releases in your email. First Name × Error: A field is missing data or special characters were used. Please correct. Last Name *Required × Error: A field is missi…
Two UT Southwestern faculty members inducted into Shine Academy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/shine-academy.html
In recognition of outstanding teaching, the UT System’s Kenneth I. Shine, M.D., Academy of Health Science Education is inducting two UT Southwestern educators as new members during its annual conference in Austin.
New combination drug therapy offers hope against methamphetamine addiction: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/methamphetamine-addiction.html
A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.
UT Southwestern investigators report first analysis of pioneering kidney cancer radiation approach in clinical trial: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/kidney-cancer-radiation.html
A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.
A different ChIA-PET provides insight into prostate cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/prostate-cancer.html
UT Southwestern researchers have identified vast webs of small snippets of the genome that interact with each other and with genes to promote prostate cancer.
Distinguishing between two very similar pediatric brain conditions: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/pediatric-brain-conditions.html
Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests.
Roughly 6,000 UT Southwestern caregivers receive COVID-19 vaccine: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/caregivers-receive-vaccine.html
Nearly 6,000 front-line health care workers at UT Southwestern have received initial doses of the COVID-19 vaccine since the Medical Center received its first shipment of 5,850 doses on Dec. 15.
Dallas Heart Study yields new insights about depression: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/dallas-heart-study.html
Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.
Study challenges concerns over hospital readmission reduction practices: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/hospital-readmission.html
A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.